Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of the CO-rebreathing Method in Stable Coronary Artery Disease and COPD Patients

NCT01470274 is registered in ClinicalTrials.gov with Norwegian University of Science and Technology as lead sponsor.

NCT NCT01470274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01470274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of the CO-rebreathing Method in Stable Coronary Artery Disease and COPD Patients
Lead sponsor
Norwegian University of Science and Technology
Phase
Observational
Overall status
Completed
Start date
November 30, 2011
Completion date
February 29, 2012
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, chronic obstructive pulmonary disease